Nicolas Gerst Ph.D.

Co-Founder of Laboratory Equipment Services, LLC - Pipette and analytical balance calibration

Greater Chicago Area

About

Laboratory Equipment Services, LLC is a on-site calibration company that specializes in the calibration of pipettes and analytical balances. We offer quality services by skilled technicians with many years of experience. We also provide flexible availability and competitive pricing. Contact us at [email protected] Previous Experience: Research pharmacologist with several years experience in drug metabolism and pharmacokinetics for drug discovery. Developed analytical methods to measure small molecules in biological matrices by LC-MS/MS. Pioneered drug screening and assays focused on hepatic metabolism, transporters and usage of human hepatocytes. Evaluated the impact of Aldehyde Oxidase (AO) on the bioavailability of some classes of drug. Investigated the usage of stem cells (iPS cells) for drug metabolism screening as an alternative to human hepatocytes.

Experience

  • Co-Founder and Director of Operations at Laboratory Equipment Services, LLC
    Aug 2019 - Present · 6 yrs 11 mos

    Calibration and maintenance of small laboratory instruments: - Calibration of Pipettes and Analytical Balances - Maintenance of microscopes

  • Validation Consultant - Research Scientist at Universal Quality Solutions, Inc
    Sep 2015 - Mar 2019 · 3 yrs 7 mos

    Performed qualification of scientific equipment like cryogenic liquid nitrogen freezers, refrigerators, incubators and gas analyzers. Designed and executed protocols for facilities validation. Wrote reports and made recommendations. Wrote protocols; user requirements specification (URS), installation qualification (IQ), operational qualification (OQ), performance qualification (PQ).

  • Astellas Pharma (Greater Chicago Area)
    • Manager DMPK
      Nov 2011 - Aug 2013 · 1 yr 10 mos

      Designed and implemented ADME/PK program for Immunology/transplantation and CNS projects for small molecules at the discovery stage to evaluate potential for drug development. Represented DMPK functions on drug discovery project teams. Designed and conducted more than 50 DMPK profiles of small molecules for transplantation, auto-immune diseases and CNS including ADME in vitro and PK studies. Developed and present recommendations based on data evaluation and interpretation to internal teams and senior management in US and Japan.

    • Principal Scientist
      Jul 2000 - Oct 2011 · 11 yrs 4 mos

      Provided DMPK support for all Transplantation and CNS projects (at this location): - ADME profile: microsomes stability, CYP inhibition (DDI), Solubility, Absorption, Protein Binding - Analysis and interpretation of ADME data for choosing pre-lead compounds - PK prior all testing in vivo to find an efficacious dose (according to in vitro data) in efficacy models. - PK/PD analysis Lead the bio-analytical lab for drug discovery: -Developed and validated LC/MS/MS methods for drug metabolism and PK profiles Directed a team (2 people) responsible for the development and implementation of new technologies to enhance drug metabolism studues supporting discovery projects; special emphasis on intestinal absorption, hepatic clearance and drug transporters. Evaluated CRO data for outsourced assays including solubility and absorption (PAMPA).

  • Senior Scientist at Fujisawa
    Feb 1998 - Jun 2000 · 2 yrs 5 mos

    Measured induction of CYP enzymes by RT-PCR in human and rat primary hepatocytes. Wrote IRB protocol to obtain specimen for ADME research projects

  • Biochemistry/Cell Biology Post-Doctorate at Rice University
    Jan 1990 - Jan 1998 · 8 yrs 1 mo

    Analyzed metabolites of synthetic oxysterols (compounds to inhibit cholesterol biosynthesis) in vitro and in vivo. Isolated intestinal microsomes and performed in vitro assays with inhibitors of ACAT an enzyme thought to regulate cholesterol levels. Adapted analytical methods for complete separation and identification of sterol precursors in Smith-Lemli-Opitz syndrome.